Key facts
- This page summarizes Jane Wright-Mitchell's Form 3 filing for Vera Therapeutics, Inc. (VERA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 25 Mar 2026, 19:06.
Jane Wright-Mitchell - 23 Mar 2026 Form 3 Insider Report for Vera Therapeutics, Inc. (VERA)
- Reporting relationship
- Chief Legal Officer
- Issuer ticker
- VERA
- Reported as of
- 23 Mar 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 25 Mar 2026, 19:06:41 UTC
- Prior SEC filing
- 18 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph R. Young, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jane Wright-Mitchell filed Form 3 for Vera Therapeutics, Inc. (VERA) on 25 Mar 2026.
Change
- Previous filing in this sequence was filed on 18 Aug 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001614568
Primary reporting owner
Wright-Mitchell Jane
- Relationship
- Chief Legal Officer
- Address
- C/O VERA THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
- Signature
- /s/ Joseph R. Young, Attorney-in-Fact
- Signature date
- 25 Mar 2026
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.